Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Cervical Cancer | Research

Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population

Authors: Nan Lv, Yue Zhao, Yiying Song, Mingyu Ji, Yunying Zhou

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

HPV16 and 18 are positively correlated with cervical carcinogenesis. However, HPV prevalence tends to vary according to region, nationality, and environment. The most prevalent high-risk (HR) HPV genotypes are HPV16, 52, 58, 56, 18, 33, and 45), while the low-risk (LR) genotypes are HPV6 and 11 in the Chinese population. Importantly, undetectable low-copy HPV DNA could be an important indicator of integration into the human genome and may be a precursor to cancer progression. The HPV viral load changes dramatically, either increasing or decreasing rapidly during carcinogenesis, and traditional quantitative real-time PCR (qPCR) cannot accurately capture this subtle change. Therefore, in this study, a reliable droplet digital PCR (ddPCR) method was developed to simultaneously detect and quantify HPV genotypes. The ddPCR quantitative results showed high accuracy, sensitivity, and specificity compared to qPCR results employing the same clinical specimens and supplemented the ddPCR assay for HPV52/56/58/6 genotypes according to the infection specificity of the Chinese population. In summary, this procedure is valuable for quantifying HPV DNA, especially under conditions of low template copy number in cervical intraepithelial neoplasia (CIN) and/or cervical cancer. Additionally, this method can dynamically observe the prognosis and outcome of HPV infection and thus be used as an effective means for real-time monitoring of tumor load.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dell G, Gaston K. Human papillomaviruses and their role in Cervical cancer. Cell Mol Life Sci. 2001;58(12–13):1923–42.CrossRefPubMed Dell G, Gaston K. Human papillomaviruses and their role in Cervical cancer. Cell Mol Life Sci. 2001;58(12–13):1923–42.CrossRefPubMed
2.
go back to reference Zhu B, Liu Y, Zuo T, Cui X, Li M, Zhang J, Yu H, Piao H. The prevalence, trends, and geographical distribution of human papillomavirus Infection in China: the pooled analysis of 1.7 million women. Cancer Med. 2019;8(11):5373–85.CrossRefPubMedPubMedCentral Zhu B, Liu Y, Zuo T, Cui X, Li M, Zhang J, Yu H, Piao H. The prevalence, trends, and geographical distribution of human papillomavirus Infection in China: the pooled analysis of 1.7 million women. Cancer Med. 2019;8(11):5373–85.CrossRefPubMedPubMedCentral
3.
go back to reference Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of Cervical cancer. Vaccine. 2012;30(Suppl 5):F88–99.CrossRefPubMed Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of Cervical cancer. Vaccine. 2012;30(Suppl 5):F88–99.CrossRefPubMed
4.
go back to reference Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028.CrossRefPubMed Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028.CrossRefPubMed
5.
go back to reference Kurita T, Chitose SI, Sato K, Sakazaki T, Fukahori M, Sueyoshi S, Umeno H. Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics. Laryngoscope Invest Otolaryngol. 2019;4(1):89–94.CrossRef Kurita T, Chitose SI, Sato K, Sakazaki T, Fukahori M, Sueyoshi S, Umeno H. Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics. Laryngoscope Invest Otolaryngol. 2019;4(1):89–94.CrossRef
6.
go back to reference Tommasino M. The human papillomavirus family and its role in carcinogenesis. Sem Cancer Biol. 2014;26:13–21.CrossRef Tommasino M. The human papillomavirus family and its role in carcinogenesis. Sem Cancer Biol. 2014;26:13–21.CrossRef
7.
go back to reference Rotondo JC, Bosi S, Bassi C, Ferracin M, Lanza G, Gafà R, Magri E, Selvatici R, Torresani S, Marci R, et al. Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes. J Cell Physiol. 2015;230(4):806–12.CrossRefPubMed Rotondo JC, Bosi S, Bassi C, Ferracin M, Lanza G, Gafà R, Magri E, Selvatici R, Torresani S, Marci R, et al. Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes. J Cell Physiol. 2015;230(4):806–12.CrossRefPubMed
8.
go back to reference Di Luca D, Pilotti S, Stefanon B, Rotola A, Monini P, Tognon M, De Palo G, Rilke F, Cassai E. Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis. J Gen Virol. 1986;67(Pt 3):583–9.CrossRefPubMed Di Luca D, Pilotti S, Stefanon B, Rotola A, Monini P, Tognon M, De Palo G, Rilke F, Cassai E. Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis. J Gen Virol. 1986;67(Pt 3):583–9.CrossRefPubMed
9.
go back to reference Wang X, Zeng Y, Huang X, Zhang Y. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China. Biomed Res Int 2018; 2018:2897937. Wang X, Zeng Y, Huang X, Zhang Y. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China. Biomed Res Int 2018; 2018:2897937.
10.
go back to reference Goodman A. HPV testing as a screen for Cervical cancer. BMJ (Clinical Research ed). 2015;350:h2372.PubMed Goodman A. HPV testing as a screen for Cervical cancer. BMJ (Clinical Research ed). 2015;350:h2372.PubMed
11.
go back to reference Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83(22):8604–10.CrossRefPubMedPubMedCentral Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83(22):8604–10.CrossRefPubMedPubMedCentral
13.
go back to reference Lillsunde Larsson G, Helenius G. Digital droplet PCR (ddPCR) for the detection and quantification of HPV 16, 18, 33 and 45 - a short report. Cell Oncol (Dordrecht). 2017;40(5):521–7.CrossRef Lillsunde Larsson G, Helenius G. Digital droplet PCR (ddPCR) for the detection and quantification of HPV 16, 18, 33 and 45 - a short report. Cell Oncol (Dordrecht). 2017;40(5):521–7.CrossRef
14.
go back to reference Rotondo JC, Oton-Gonzalez L, Mazziotta C, Lanzillotti C, Iaquinta MR, Tognon M, Martini F. Simultaneous detection and viral DNA load quantification of different human papillomavirus types in clinical specimens by the High Analytical Droplet Digital PCR method. Front Microbiol. 2020;11:591452.CrossRefPubMedPubMedCentral Rotondo JC, Oton-Gonzalez L, Mazziotta C, Lanzillotti C, Iaquinta MR, Tognon M, Martini F. Simultaneous detection and viral DNA load quantification of different human papillomavirus types in clinical specimens by the High Analytical Droplet Digital PCR method. Front Microbiol. 2020;11:591452.CrossRefPubMedPubMedCentral
15.
go back to reference Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030–7.CrossRefPubMed Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030–7.CrossRefPubMed
16.
go back to reference Shoja Z, Farahmand M, Hosseini N, Jalilvand S. A Meta-analysis on human papillomavirus type distribution among women with cervical neoplasia in the WHO Eastern Mediterranean Region. Intervirology. 2019;62(3–4):101–11.CrossRefPubMed Shoja Z, Farahmand M, Hosseini N, Jalilvand S. A Meta-analysis on human papillomavirus type distribution among women with cervical neoplasia in the WHO Eastern Mediterranean Region. Intervirology. 2019;62(3–4):101–11.CrossRefPubMed
17.
go back to reference van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, Meijer CJ, Boot H, King AJ. Correlation between viral load, multiplicity of Infection, and persistence of HPV16 and HPV18 Infection in a Dutch cohort of young women. J Clin Virology: Official Publication Pan Am Soc Clin Virol. 2016;83:6–11.CrossRef van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, Meijer CJ, Boot H, King AJ. Correlation between viral load, multiplicity of Infection, and persistence of HPV16 and HPV18 Infection in a Dutch cohort of young women. J Clin Virology: Official Publication Pan Am Soc Clin Virol. 2016;83:6–11.CrossRef
18.
go back to reference Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Cervical Cancer Screening Programs in Europe: the transition towards HPV Vaccination and Population-based HPV testing. Viruses 2018; 10(12). Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Cervical Cancer Screening Programs in Europe: the transition towards HPV Vaccination and Population-based HPV testing. Viruses 2018; 10(12).
19.
20.
go back to reference Nodjikouambaye ZA, Adawaye C, Mboumba Bouassa RS, Sadjoli D, Bélec L. A systematic review of self-sampling for HPV testing in Africa. Int J Gynaecol Obstet. 2020;149(2):123–9.CrossRefPubMed Nodjikouambaye ZA, Adawaye C, Mboumba Bouassa RS, Sadjoli D, Bélec L. A systematic review of self-sampling for HPV testing in Africa. Int J Gynaecol Obstet. 2020;149(2):123–9.CrossRefPubMed
21.
go back to reference Bhatla N, Singhal S. Primary HPV screening for Cervical cancer. Best Pract Res Clin Obstet Gynecol. 2020;65:98–108.CrossRef Bhatla N, Singhal S. Primary HPV screening for Cervical cancer. Best Pract Res Clin Obstet Gynecol. 2020;65:98–108.CrossRef
22.
go back to reference Cuzick JM, Clavel C, Petry KU, Meijer CJLM, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam SL, Sasieni PD et al. Overview of the European and north American studies on HPV testing in primary Cervical cancer screening. 2006; 119. Cuzick JM, Clavel C, Petry KU, Meijer CJLM, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam SL, Sasieni PD et al. Overview of the European and north American studies on HPV testing in primary Cervical cancer screening. 2006; 119.
24.
go back to reference Taylor SC, Laperriere G, Germain H. Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci Rep. 2017;7(1):2409.CrossRefPubMedPubMedCentral Taylor SC, Laperriere G, Germain H. Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci Rep. 2017;7(1):2409.CrossRefPubMedPubMedCentral
25.
go back to reference Zhang Y, Qu S, Xu L. Progress in the study of virus detection methods: the possibility of alternative methods to validate virus inactivation. Biotechnol Bioeng. 2019;116(8):2095–102.CrossRefPubMed Zhang Y, Qu S, Xu L. Progress in the study of virus detection methods: the possibility of alternative methods to validate virus inactivation. Biotechnol Bioeng. 2019;116(8):2095–102.CrossRefPubMed
26.
go back to reference Boulter N, Suarez FG, Schibeci S, Sunderland T, Tolhurst O, Hunter T, Hodge G, Handelsman D, Simanainen U, Hendriks E, et al. A simple, accurate and universal method for quantification of PCR. BMC Biotechnol. 2016;16:27.CrossRefPubMedPubMedCentral Boulter N, Suarez FG, Schibeci S, Sunderland T, Tolhurst O, Hunter T, Hodge G, Handelsman D, Simanainen U, Hendriks E, et al. A simple, accurate and universal method for quantification of PCR. BMC Biotechnol. 2016;16:27.CrossRefPubMedPubMedCentral
27.
go back to reference Basu AS. Digital assays part I: Partitioning statistics and Digital PCR. SLAS Technol. 2017;22(4):369–86.CrossRefPubMed Basu AS. Digital assays part I: Partitioning statistics and Digital PCR. SLAS Technol. 2017;22(4):369–86.CrossRefPubMed
28.
go back to reference Katsuya H, Islam S, Tan BJY, Ito J, Miyazato P, Matsuo M, Inada Y, Iwase SC, Uchiyama Y, Hata H, et al. The nature of the HTLV-1 Provirus in naturally infected individuals analyzed by the viral DNA-Capture-Seq Approach. Cell Rep. 2019;29(3):724–735e724.CrossRefPubMed Katsuya H, Islam S, Tan BJY, Ito J, Miyazato P, Matsuo M, Inada Y, Iwase SC, Uchiyama Y, Hata H, et al. The nature of the HTLV-1 Provirus in naturally infected individuals analyzed by the viral DNA-Capture-Seq Approach. Cell Rep. 2019;29(3):724–735e724.CrossRefPubMed
29.
go back to reference Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE. 2013;8(4):e55943.CrossRefPubMedPubMedCentral Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE. 2013;8(4):e55943.CrossRefPubMedPubMedCentral
30.
go back to reference Jiang Y, Manz A, Wu W. Fully automatic integrated continuous-flow digital PCR device for absolute DNA quantification. Anal Chim Acta. 2020;1125:50–6.CrossRefPubMed Jiang Y, Manz A, Wu W. Fully automatic integrated continuous-flow digital PCR device for absolute DNA quantification. Anal Chim Acta. 2020;1125:50–6.CrossRefPubMed
31.
go back to reference Stebbing J, Bower M. Cell-free DNA as a biomarker in the context of cancer, viruses, and methylation. J Infect Dis. 2012;205(7):1032–4.CrossRefPubMed Stebbing J, Bower M. Cell-free DNA as a biomarker in the context of cancer, viruses, and methylation. J Infect Dis. 2012;205(7):1032–4.CrossRefPubMed
32.
go back to reference White RA 3rd, Blainey PC, Fan HC, Quake SR. Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics. 2009;10:116.CrossRefPubMedPubMedCentral White RA 3rd, Blainey PC, Fan HC, Quake SR. Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics. 2009;10:116.CrossRefPubMedPubMedCentral
33.
go back to reference Postel M, Roosen A, Laurent-Puig P, Taly V, Wang-Renault SF. Droplet-based digital PCR and next generation sequencing for monitoring circulating Tumor DNA: a cancer diagnostic perspective. Expert Rev Mol Diagn. 2018;18(1):7–17.CrossRefPubMed Postel M, Roosen A, Laurent-Puig P, Taly V, Wang-Renault SF. Droplet-based digital PCR and next generation sequencing for monitoring circulating Tumor DNA: a cancer diagnostic perspective. Expert Rev Mol Diagn. 2018;18(1):7–17.CrossRefPubMed
34.
go back to reference Miyaoka Y, Mayerl SJ, Chan AH, Conklin BR. Detection and quantification of HDR and NHEJ Induced by Genome Editing at endogenous gene loci using Droplet Digital PCR. Methods in Molecular Biology (Clifton NJ). 2018;1768:349–62.CrossRef Miyaoka Y, Mayerl SJ, Chan AH, Conklin BR. Detection and quantification of HDR and NHEJ Induced by Genome Editing at endogenous gene loci using Droplet Digital PCR. Methods in Molecular Biology (Clifton NJ). 2018;1768:349–62.CrossRef
35.
go back to reference Thangarajah F, Busshoff J, Salamon J, Pruss MS, Lenz C, Morgenstern B, Hellmich M, Schlößer HA, Lenz M, Domröse C et al. Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer. J Cancer Res Clin Oncol 2023. Thangarajah F, Busshoff J, Salamon J, Pruss MS, Lenz C, Morgenstern B, Hellmich M, Schlößer HA, Lenz M, Domröse C et al. Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer. J Cancer Res Clin Oncol 2023.
36.
go back to reference Gu W, Zhang P, Zhang G, Zhou J, Ding X, Wang Q, Wang B, Wei Y, Jin S, Ye D, et al. Importance of HPV in Chinese Penile Cancer: a contemporary Multicenter Study. Front Oncol. 2020;10:1521.CrossRefPubMedPubMedCentral Gu W, Zhang P, Zhang G, Zhou J, Ding X, Wang Q, Wang B, Wei Y, Jin S, Ye D, et al. Importance of HPV in Chinese Penile Cancer: a contemporary Multicenter Study. Front Oncol. 2020;10:1521.CrossRefPubMedPubMedCentral
37.
go back to reference Jeannot E, Becette V, Campitelli M, Calméjane MA, Lappartient E, Ruff E, Saada S, Holmes A, Bellet D, Sastre-Garau X. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma. J Pathol Clin Res. 2016;2(4):201–9.CrossRefPubMedPubMedCentral Jeannot E, Becette V, Campitelli M, Calméjane MA, Lappartient E, Ruff E, Saada S, Holmes A, Bellet D, Sastre-Garau X. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma. J Pathol Clin Res. 2016;2(4):201–9.CrossRefPubMedPubMedCentral
38.
go back to reference de Araujo MR, De Marco L, Santos CF, Rubira-Bullen IR, Ronco G, Pennini I, Vizzini L, Merletti F, Gillio-Tos A. GP5+/6 + SYBR Green methodology for simultaneous screening and quantification of human papillomavirus. J Clin Virology: Official Publication Pan Am Soc Clin Virol. 2009;45(2):90–5.CrossRef de Araujo MR, De Marco L, Santos CF, Rubira-Bullen IR, Ronco G, Pennini I, Vizzini L, Merletti F, Gillio-Tos A. GP5+/6 + SYBR Green methodology for simultaneous screening and quantification of human papillomavirus. J Clin Virology: Official Publication Pan Am Soc Clin Virol. 2009;45(2):90–5.CrossRef
39.
go back to reference Carow K, Gölitz M, Wolf M, Häfner N, Jansen L, Hoyer H, Schwarz E, Runnebaum IB, Dürst M. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA. International journal of molecular sciences 2017; 18(10). Carow K, Gölitz M, Wolf M, Häfner N, Jansen L, Hoyer H, Schwarz E, Runnebaum IB, Dürst M. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA. International journal of molecular sciences 2017; 18(10).
40.
go back to reference Holmes A, Lameiras S, Jeannot E, Marie Y, Castera L, Sastre-Garau X, Nicolas A. Mechanistic signatures of HPV insertions in cervical carcinomas. NPJ Genomic Medicine. 2016;1:16004.CrossRefPubMedPubMedCentral Holmes A, Lameiras S, Jeannot E, Marie Y, Castera L, Sastre-Garau X, Nicolas A. Mechanistic signatures of HPV insertions in cervical carcinomas. NPJ Genomic Medicine. 2016;1:16004.CrossRefPubMedPubMedCentral
41.
go back to reference Kang Z, Stevanović S, Hinrichs CS, Cao L. Circulating cell-free DNA for metastatic Cervical Cancer detection, genotyping, and monitoring. Clin Cancer Res. 2017;23(22):6856–62.CrossRefPubMedPubMedCentral Kang Z, Stevanović S, Hinrichs CS, Cao L. Circulating cell-free DNA for metastatic Cervical Cancer detection, genotyping, and monitoring. Clin Cancer Res. 2017;23(22):6856–62.CrossRefPubMedPubMedCentral
42.
go back to reference Jeannot E, Latouche A, Bonneau C, Calméjane M-A, Beaufort CM, Ruigrok-Ritstier K, Bataillon G, Larbi Chérif L, Dupain C, Lecerf C et al. Circulating HPV DNA as a marker for early detection of Relapse in patients with Cervical Cancer. 2021; 27:5869–77. Jeannot E, Latouche A, Bonneau C, Calméjane M-A, Beaufort CM, Ruigrok-Ritstier K, Bataillon G, Larbi Chérif L, Dupain C, Lecerf C et al. Circulating HPV DNA as a marker for early detection of Relapse in patients with Cervical Cancer. 2021; 27:5869–77.
43.
go back to reference Cabel L, Bonneau C, Bernard-Tessier A, Héquet D, Tran-Perennou C, Bataillon G, Rouzier R, Féron JG, Fourchotte V, Le Brun JF, et al. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced Cervical cancer. ESMO open. 2021;6(3):100154.CrossRefPubMedPubMedCentral Cabel L, Bonneau C, Bernard-Tessier A, Héquet D, Tran-Perennou C, Bataillon G, Rouzier R, Féron JG, Fourchotte V, Le Brun JF, et al. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced Cervical cancer. ESMO open. 2021;6(3):100154.CrossRefPubMedPubMedCentral
Metadata
Title
Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population
Authors
Nan Lv
Yue Zhao
Yiying Song
Mingyu Ji
Yunying Zhou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11529-3

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine